Skip to main content

CVF, LLC's Form 4 filing

Fractyl Health, Inc. (GUTS) · filed Feb 6, 2024

Accession no.
0000899243-24-000153
Filed
Feb 6, 2024, 8:39 PM ET
Trade date
Feb 6, 2024
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 4 derivative transactions. Open-market purchases total $5.00M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
CVF, LLCCIK 000111227810% Owner
HCC Manager LLCCIK 0001844818Other: (4)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2024Common StockCConversionAcquired+3,419,876––3,419,876Direct
Feb 6, 2024Common StockCConversionAcquired+920,661––4,340,537Direct
Feb 6, 2024Common StockPPurchaseAcquired+333,333$15.00+$4,999,9954,673,870Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2024Series D Preferred StockCConversionDisposed−4,090,872––0Direct
Feb 6, 2024Series E Preferred StockCConversionDisposed−2,914,228––0Direct
Feb 6, 2024Series F Preferred StockCConversionDisposed−333,957––0Direct
Feb 6, 2024Convertible Promissory NoteCConversionDisposed0––0Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)